Modeling the Transmission Dynamics of COVID-19 Among Five High Burden African Countries

References

• CDC. Novel Coronavirus, Wuhan, China. CDC; 2019. Available from: https://www.cdc.gov/coronavirus/2019-ncov/about/index.html. Accessed August 23, 2022.
   Google Scholar
• Worldometer. Coronavirus Cases and Deaths. Delaware, USA: Dover; 2020.
   Google Scholar
• Namazi H, Krejcar O, Subasi A. Complexity and information-based analysis of the variations of the SARS-CoV-2 genome in the United States of America (USA). Fractals. 2020;28(07):2150023. doi:10.1142/S0218348X21500237
   Web of Science ®Google Scholar
• Rahman A, Kuddus MA. Kuddus MAM the transmission dynamics of C-19 in six high-burden countries. Modelling the transmission dynamics of COVID-19 in six high-burden countries. Biomed Res Int. 2021;2021:1–17. doi:10.1155/2021/5089184
   Web of Science ®Google Scholar
• Tsang CA, Tabnak F, Vugia DJ, Benedict K, Chiller T, Park BJ. Increase in reported coccidioidomycosis—United States, 1998–2011. MMWR Morb Mortal Wkly Rep. 2013;62(12):217.
   PubMed Web of Science ®Google Scholar
• Bialek S, Bowen V, Chow N, et al.; Covid CDC, Team R. Geographic differences in COVID-19 cases, deaths, and incidence—United States, February 12–April 7, 2020. Morb Mortal Wkly Rep. 2020;69(15):465. doi:10.15585/mmwr.mm6915e4
   PubMed Web of Science ®Google Scholar
• Suresh R, James J, RSJ B. Migrant workers at crossroads–The COVID-19 pandemic and the migrant experience in India. Soc Work Public Health. 2020;35(7):633–643. doi:10.1080/19371918.2020.1808552
   PubMed Web of Science ®Google Scholar
• Pai C, Bhaskar A, Rawoot V. Investigating the dynamics of COVID-19 pandemic in India under lockdown. Chaos Solitons Fractals. 2020;138:109988. doi:10.1016/j.chaos.2020.109988
   PubMed Web of Science ®Google Scholar
• Singh AK, Misra A. Impact of COVID-19 and comorbidities on health and economics: focus on developing countries and India. Diabetes Metab Syndr Clin Res Rev. 2020;14(6):1625–1630. doi:10.1016/j.dsx.2020.08.032
   Web of Science ®Google Scholar
• Ghosh A, Nundy S, Mallick TK. How India is dealing with the COVID-19 pandemic. Sensors Int. 2020;1:100021. doi:10.1016/j.sintl.2020.100021
   PubMedGoogle Scholar
• Gilbert M, Pullano G, Pinotti F, et al. Preparedness and vulnerability of African countries against importations of COVID-19: a modeling study. Lancet. 2020;395(10227):871–877. doi:10.1016/S0140-6736(20)30411-6
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus (COVID-19) Dashboard. World Health Organization; 2021. Available from: https://covid19.who.int/. Accessed 10 July, 2021.
   Google Scholar
• World Health Organization. African W. Coronavirus (COVID-19): WHO African Region numbers at a glance; 2021.
   Google Scholar
• Tull DM. China’s engagement in Africa: scope, significance, and consequences. J Mod Afr Stud. 2006;44(3):459–479. doi:10.1017/S0022278X06001856
   Web of Science ®Google Scholar
• George G, Corbishley C, Khayesi JNO, Haas MR, Tihanyi L. Bringing Africa i: promising directions for management research. Acad Manag Ann. 2016;59:377–393. doi:10.5465/amj.2016.4002
   Web of Science ®Google Scholar
• Dzinamarira T, Dzobo M, Chitungo I. COVID‐19: a perspective on Africa’s capacity and response. J Med Virol. 2020;92(11):2465–2472. doi:10.1002/jmv.26159
   Web of Science ®Google Scholar
• Iyaniwura SA, Rabiu M, David JF, Kong JD. The basic reproduction number of COVID-19 across Africa. PLoS One. 2022;17(2):e0264455. doi:10.1371/journal.pone.0264455
   Web of Science ®Google Scholar
• GARDAWORLD. Ghana: authorities impose a lockdown on two regions due to COVID-19 from March 30; 2021.
   Google Scholar
• World Health Organization. Update on omicron; 2021. Available from: https://www.who.int/news/item/28-11-2021-update-on-omicron. Accessed November 30, 2021.
   Google Scholar
• Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021;398(10317):2126–2128. doi:10.1016/S0140-6736(21)02758-6
   PubMed Web of Science ®Google Scholar
• Gerli AG, Centanni S, Soriano JB, Ancochea J. Forecasting COVID-19 infection trends and new hospital admissions in England due to SARS-CoV-2 Variant of Concern Omicron. medRxiv. 2021.
   Google Scholar
• Morse SS. Factors in the emergence of infectious diseases. Plagues Polit. 2001;8–26. doi:10.1101/2021.12.29.21268521.
   Google Scholar
• Luria SE, Delbrück M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics. 1943;28(6):491. doi:10.1093/genetics/28.6.491
   PubMedGoogle Scholar
• Narouei M, Ahmadi M, Giacinto G, Takagibi H, Sami A. DLLMiner: structural mining for malware detection. Secur Commun Networks. 2015;8(18):3311–3322. doi:10.1002/sec.1255
   Web of Science ®Google Scholar
• Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog. 2010;6(7):e1001005. doi:10.1371/journal.ppat.1001005
   PubMed Web of Science ®Google Scholar
• CDC. Science brief: Omicron (B.1.1.529) variant. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/. Accessed December 2, 2021.
   Google Scholar
• COVID CDC, Team R. SARS-CoV-2 B. 1.1. 529 (Omicron) Varianthe t—the United States, December 1 –8, 2021. Morb Mortal Wkly Rep. 2021;70(50):1731. doi:10.15585/mmwr.mm7050e1
   Web of Science ®Google Scholar
• Walensky RP, Del Rio C. From mitigation to containment of the COVID-19 pandemic: putting the SARS-CoV-2 genie back in the bottle. JAMA. 2020;323(19):1889–1890. doi:10.1001/jama.2020.6572
   PubMed Web of Science ®Google Scholar
• Haldane V, De Foo C, Abdalla SM, et al. Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nat Med. 2021;27(6):964–980. doi:10.1038/s41591-021-01381-y
   PubMed Web of Science ®Google Scholar
• Le K, Nguyen M. The psychological burden of the COVID-19 pandemic severity. Econ Hum Biol. 2021;41:100979. doi:10.1016/j.ehb.2021.100979
   PubMed Web of Science ®Google Scholar
• Stock PG, Wall A, Gardner J, et al. Ethical issues in the COVID era: doing the right thing depends on location, resources, and disease burden. Transplantation. 2020;104(7):1316. doi:10.1097/TP.0000000000003291
   Web of Science ®Google Scholar
• Togun T, Kampmann B, Stoker NG, Lipman M. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Ann Clin Microbiol Antimicrob. 2020;19(1):1–6. doi:10.1186/s12941-020-00363-1
   Web of Science ®Google Scholar
• Biswas RK, Huq S, Afiaz A, Khan HTA. A systematic assessment of COVID‐19 preparedness and transition strategy in Bangladesh. J Eval Clin Pract. 2020;26(6):1599–1611. doi:10.1111/jep.13467
   PubMed Web of Science ®Google Scholar
• Jamison AM, Quinn SC, Freimuth VS. “You don’t trust a government vaccine”: narratives of institutional trust and influenza vaccination among African American and white adults. Soc Sci Med. 2019;221:87–94. doi:10.1016/j.socscimed.2018.12.020
   PubMed Web of Science ®Google Scholar
• Wigle J, Coast E, Watson-Jones D. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects. Vaccine. 2013;31(37):3811–3817. doi:10.1016/j.vaccine.2013.06.016
   PubMed Web of Science ®Google Scholar
• Joseph NP, Clark JA, Mercilus G, Wilbur M, Figaro J, Perkins R. Racial and ethnic differences in HPV knowledge, attitudes, and vaccination rates among low-income African-American, Haitian, Latina, and Caucasian young adult women. J Pediatr Adolesc Gynecol. 2014;27(2):83–92. doi:10.1016/j.jpag.2013.08.011
   PubMed Web of Science ®Google Scholar
• Falcó‐Pegueroles A, Zuriguel‐Pérez E, Via‐Clavero G, Bosch‐Alcaraz A, Bonetti L. Ethical conflict during COVID‐19 pandemic: the case of Spanish and Italian intensive care units. Int Nurs Rev. 2021;68(2):181–188. doi:10.1111/inr.12645
   Web of Science ®Google Scholar
• Christaki E. New technologies in predicting, preventing and controlling emerging infectious diseases. Virulence. 2015;6(6):558–565. doi:10.1080/21505594.2015.1040975
   PubMed Web of Science ®Google Scholar
• Diekmann O, Heesterbeek H, Britton T. Mathematical Tools for Understanding Infectious Disease Dynamics. Princeton University Press; 2012.
   Google Scholar
• Heesterbeek H, Anderson RM, Andreasen V, et al. Modeling infectious disease dynamics in the complex landscape of global health. Science. 2015;347(6227):aaa4339. doi:10.1126/science.aaa4339
   PubMed Web of Science ®Google Scholar
• Vynnycky E, White R. An introduction to infectious disease modelling. In: OUP oxford; 2010:13.
   Google Scholar
• Wang P, Jia J. Stationary distribution of a stochastic SIRD epidemic model of Ebola with double saturated incidence rates and vaccination. Adv Differ Equ. 2019;2019:433. doi:10.1186/s13662-019-2352-5
   Web of Science ®Google Scholar
• Anastassopoulou C, Russo L, Tsakris A, Siettos C. Data based analysis, modelling and forecasting of the COVID-19 outbreak. PLoS One. 2020;15:e0230405. doi:10.1371/journal.pone.0230405
   PubMed Web of Science ®Google Scholar
• Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One. 2020;15:e0230548. doi:10.1371/journal.pone.0230548
   PubMed Web of Science ®Google Scholar
• Heaton PM, Douoguih M. Booster dose of Janssen COVID-19 Vaccine (Ad26. COV2. S) following primary vaccination; 2021.
   Google Scholar
• Flacco ME, Soldato G, Martellucci CA, et al. Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: data from an Italian Province. Vaccines. 2021;9:628. doi:10.3390/vaccines9060628
   PubMed Web of Science ®Google Scholar
• Kissling E, Hooiveld M, Martı´n VS, et al. Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: i-MOVE-COVID-19 project, Europe, December 2020 to May 2021. Eurosurveillance. 2021;26:2100670. doi:10.2807/1560-7917.ES
   Web of Science ®Google Scholar
• Bernal JL, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:373. PMID: 33985964.
   Google Scholar
• Martı´nez-Baz I, Miqueleiz A, Casado I, et al. Effectiveness of COVID-19 vaccines in preventing SARS CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021. Eurosurveillance. 2021;26:2100438. PMID: 34047271. doi:10.2807/1560-7917.ES.2021.26.21.2100438
   Web of Science ®Google Scholar
• Pritchard E, Matthews PC, Stoesser N, et al. Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nat Med. 2021;27:1370–1378. PMID: 34108716. doi:10.1038/s41591-021-01410-w
   PubMed Web of Science ®Google Scholar
• Thompson MG, Burgess JL, Naleway AL, et al. Interim Estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers—Eight U.S. Locations. 2021;70:495–500. PMID: 33793460. doi:10.15585/mmwr.mm7013e3
   Web of Science ®Google Scholar
• Amit S, Regev-Yochay G, Afek A, et al. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet. 2021;397:875–877. doi:10.1016/S0140-6736
   PubMed Web of Science ®Google Scholar
• Jara A, Undurraga EA, Gonza´lez C, et al. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. N Engl J Med. 2021;385:875–884. PMID: 34233097. doi:10.1056/NEJMoa2107715
   PubMed Web of Science ®Google Scholar
• Harris RJ, Hall JA, Zaidi A, et al. Effect of Vaccination on Household Transmission of SARS-CoV-2 in England. N Engl J Med. 2021;385:759–760. PMID: 34161702. doi:10.1056/NEJMc2107717
   PubMed Web of Science ®Google Scholar
• Thompson MG, Burgess JL, Naleway AL, et al. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. N Engl J Med. 2021;385:320–329. PMID: 34192428. doi:10.1056/NEJMoa2107058
   PubMed Web of Science ®Google Scholar